We are live on ! Find out more
HCM

Highlander Capital Management Portfolio holdings

AUM $292M
1-Year Est. Return 22.24%
This Fund
S&P 500
This Quarter Est. Return
+20.79%
1 Year Est. Return
+22.24%
3 Year Est. Return
+34.41%
5 Year Est. Return
+97.97%
10 Year Est. Return
+157.93%
AUM
$159M
AUM Growth
+$19.5M
Cap. Flow
-$22M
Cap. Flow %
-13.87%
Top 10 Hldgs %
30.41%
Holding
660
New
12
Increased
62
Reduced
55
Closed
65

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$514K
2
PFE icon
Pfizer
PFE
+$474K
3
CVX icon
Chevron
CVX
+$342K
4
HD icon
Home Depot
HD
+$315K
5
PSLV icon
Sprott Physical Silver Trust
PSLV
+$284K

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$577K
2
UAL icon
United Airlines
UAL
+$443K
3
NVDA icon
NVIDIA
NVDA
+$388K
4
UMH
UMH Properties
UMH
+$362K
5
CC icon
Chemours
CC
+$329K

Sector Composition

Rank Sector Weight
1 Healthcare 19.9%
2 Technology 12.71%
3 Financials 12.03%
4 Consumer Discretionary 8.42%
5 Communication Services 7.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNH icon
1
UnitedHealth
UNH
$386B
$7.21M 4.55%
24,440
AAPL icon
2
Apple
AAPL
$5.03T
$6.42M 4.05%
70,384
-2,000
-3% -$155K
MSFT icon
3
Microsoft
MSFT
$2.96T
$6.36M 4.01%
31,265
AMGN icon
4
Amgen
AMGN
$210B
$5.43M 3.43%
23,040
SYK icon
5
Stryker
SYK
$134B
$4.92M 3.1%
27,300
BRK.B icon
6
Berkshire Hathaway Class B
BRK.B
$1.1T
$4.71M 2.97%
26,370
+350
+1% +$63.9K
HD icon
7
Home Depot
HD
$340B
$4M 2.52%
15,975
+1,375
+9% +$315K
AMZN icon
8
Amazon
AMZN
$2.49T
$3.44M 2.17%
24,900
-100
-0.4% -$12.1K
CSCO icon
9
Cisco
CSCO
$454B
$2.97M 1.87%
63,669
+50
+0.1% +$2.19K
JNJ icon
10
Johnson & Johnson
JNJ
$640B
$2.75M 1.73%
19,550
GOOG icon
11
Alphabet (Google) Class C
GOOG
$4.16T
$2.55M 1.61%
36,060
DIS icon
12
Walt Disney
DIS
$171B
$2.4M 1.52%
21,552
+65
+0.3% +$7.18K
CVS icon
13
CVS Health
CVS
$137B
$2.27M 1.43%
34,900
-9,155
-21% -$577K
COST icon
14
Costco
COST
$431B
$1.93M 1.22%
6,357
PH icon
15
Parker-Hannifin
PH
$121B
$1.89M 1.19%
10,325
-300
-3% -$48.4K
BA icon
16
Boeing
BA
$171B
$1.85M 1.17%
10,075
-200
-2% -$30.7K
BNY
17
Bank of New York Mellon
BNY
$105B
$1.81M 1.14%
46,714
-445
-0.9% -$16.3K
PEP icon
18
PepsiCo
PEP
$195B
$1.8M 1.14%
13,624
CNX icon
19
CNX Resources
CNX
$4.92B
$1.78M 1.13%
206,250
+2,650
+1% +$26.7K
DLTR icon
20
Dollar Tree
DLTR
$24.9B
$1.72M 1.08%
18,500
-500
-3% -$41.7K
ISRG icon
21
Intuitive Surgical
ISRG
$127B
$1.71M 1.08%
9,000
T icon
22
AT&T
T
$163B
$1.7M 1.07%
74,572
+22,565
+43% +$514K
PG icon
23
Procter & Gamble
PG
$337B
$1.52M 0.96%
12,703
LBAI
24
DELISTED
Lakeland Bancorp Inc
LBAI
$1.46M 0.92%
127,925
MDT icon
25
Medtronic
MDT
$112B
$1.45M 0.92%
15,856
+2,200
+16% +$211K

Similar funds

Highlander Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Highlander Capital Management held 660 positions worth $159M, up 14% from $139M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Highlander Capital Management withdrew a net $22M in Q2 2020, closing 65 positions and reducing 55 holdings. Its most notable exit was Humana, an estimated $314K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Financials.

Against the trend, Highlander Capital Management opened a new position in Invesco Pharmaceuticals ETF worth $52K.

  • Highlander Capital Management's largest Q2 2020 buy was Invesco Pharmaceuticals ETF: 800 shares worth $52K.
  • Highlander Capital Management added most to AT&T in Q2 2020, an estimated $514K increase.
  • Highlander Capital Management's biggest Q2 2020 reduction was CVS Health, cutting an estimated $577K.
  • Highlander Capital Management fully exited Humana in Q2 2020, selling an estimated $314K.
  • Highlander Capital Management's ten largest holdings make up 30% of its $159M portfolio in Q2 2020.
  • Highlander Capital Management opened 12 new positions and closed 65 in Q2 2020.
  • Highlander Capital Management's portfolio value rose 14% quarter-over-quarter to $159M.

Based on Highlander Capital Management's 13F filing for Q2 2020, filed 17 Aug 2020.